Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Keeps 4 Point Gain. More details...
Poor Growth Predicted. More details...
CBT 200 Down A Fraction. More details...
CBT 200 Closes At All-time High. More details...
CBT 200 Climbs Again. More details...
What Do Averages Really Mean?. More details...
Biotech Virtually Flat Today. More details...
CBT 200 Ends Week With Small Gain. More details...
CBT 200 Down 14 Points. More details...
CBT 200 Gains 30 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
